Last 12 months
Inside the activity.
0 purchase rows · 53 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 11 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2021 Filed Apr 16, 2021 23:23 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
SaleCommon Stock | 1,200 | $180.67 | $216,804.00 |
DisclosureSEC source: 0000899243-21-016134 · doc4.xml · nonDerivative · entry 2 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,854 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.11 to $181.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:23 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
Exercise / conversionCommon Stock | 1,200 | $28.32 | $33,984.00 |
DisclosureSEC source: 0000899243-21-016134 · doc4.xml · nonDerivative · entry 1 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:20 UTC |
GEIGER JESSE JCFO & COO, Lab Operations
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0000899243-21-016132 · doc4.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 3,000 shares Expires 2024-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each option vested on March 15, 2021. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:20 UTC |
GEIGER JESSE JCFO & COO, Lab Operations
|
SaleCommon Stock | 3,000 | $180.00 | $540,000.00 |
DisclosureSEC source: 0000899243-21-016132 · doc4.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:20 UTC |
GEIGER JESSE JCFO & COO, Lab Operations
|
Exercise / conversionCommon Stock | 3,000 | $28.32 | $84,960.00 |
DisclosureSEC source: 0000899243-21-016132 · doc4.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:20 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 3,720 | $180.48 | $671,385.60 |
DisclosureSEC source: 0000899243-21-016131 · doc4.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,453,482 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.55. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:05 UTC |
BURWIG SUSAN EExec. VP, Operations
|
SaleCommon Stock | 6,211 | $167.00 | $1,037,237.00 |
DisclosureSEC source: 0001567619-21-005738 · doc1.xml · nonDerivative · entry 1 BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,005 Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:32 UTC |
GEIGER JESSE JCFO & COO, Lab Operations
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-21-003082 · doc1.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each option vested on August 10, 2020. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:32 UTC |
GEIGER JESSE JCFO & COO, Lab Operations
|
SaleCommon Stock | 4,000 | $160.00 | $640,000.00 |
DisclosureSEC source: 0001567619-21-003082 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:32 UTC |
GEIGER JESSE JCFO & COO, Lab Operations
|
Exercise / conversionCommon Stock | 4,000 | $23.00 | $92,000.00 |
DisclosureSEC source: 0001567619-21-003082 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:29 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001567619-21-003077 · doc1.xml · derivative · entry 3 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each option vested on August 5, 2019. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:29 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
SaleCommon Stock | 10,000 | $155.48 | $1,554,800.00 |
DisclosureSEC source: 0001567619-21-003077 · doc1.xml · nonDerivative · entry 2 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,854 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $155.00 to $156.17. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:29 UTC |
EWALD STEPHEN PGeneral Counsel & Corp. Secy.
|
Exercise / conversionCommon Stock | 10,000 | $90.65 | $906,500.00 |
DisclosureSEC source: 0001567619-21-003077 · doc1.xml · nonDerivative · entry 1 EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 21:22 UTC |
Medpace Investors, LLC10% owner
|
SaleCommon Stock | 26,666 | $140.71 | $3,752,172.86 |
DisclosureSEC source: 0001567619-21-000860 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,457,202 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $142.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 21:20 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 26,666 | $140.71 | $3,752,172.86 |
DisclosureSEC source: 0001567619-21-000859 · doc1.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,457,202 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $142.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:06 UTC |
Medpace Investors, LLC10% owner
|
SaleCommon Stock | 93,552 | $140.06 | $13,102,893.12 |
DisclosureSEC source: 0001567619-21-000814 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,483,868 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.425. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 93,552 | $140.06 | $13,102,893.12 |
DisclosureSEC source: 0001567619-21-000813 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,483,868 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.425. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,112 | $0.00 Strike: $18.23 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 10 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,112 shares Expires 2023-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,887 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 9 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,887 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 65,305 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 8 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,305 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,925 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 7 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,925 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 92,118 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 6 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92,118 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionCommon Stock | 11,112 | $18.23 | $202,571.76 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 5 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,669,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionCommon Stock | 10,887 | $16.88 | $183,772.56 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,657,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionCommon Stock | 65,305 | $16.20 | $1,057,941.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,647,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionCommon Stock | 5,925 | $14.41 | $85,379.25 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,581,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
Exercise / conversionCommon Stock | 92,118 | $14.41 | $1,327,420.38 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,575,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,112 | $0.00 Strike: $18.23 | $0.00 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · derivative · entry 11 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 0 Underlying: Common Stock · 11,112 shares Expires 2023-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,887 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · derivative · entry 10 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 0 Underlying: Common Stock · 10,887 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 65,305 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · derivative · entry 9 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 0 Underlying: Common Stock · 65,305 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,925 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · derivative · entry 8 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 0 Underlying: Common Stock · 5,925 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 92,118 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · derivative · entry 7 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 0 Underlying: Common Stock · 92,118 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionCommon Stock | 11,112 | $18.23 | $202,571.76 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · nonDerivative · entry 5 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,669,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionCommon Stock | 10,887 | $16.88 | $183,772.56 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · nonDerivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,657,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionCommon Stock | 65,305 | $16.20 | $1,057,941.00 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,647,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionCommon Stock | 5,925 | $14.41 | $85,379.25 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,581,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionCommon Stock | 92,118 | $14.41 | $1,327,420.38 |
DisclosureSEC source: 0001567619-21-000722 · doc1.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,575,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:06 UTC |
Medpace Investors, LLC10% owner
|
SaleCommon Stock | 91,667 | $140.06 | $12,838,880.02 |
DisclosureSEC source: 0001567619-21-000814 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,577,420 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:05 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 91,667 | $140.06 | $12,838,880.02 |
DisclosureSEC source: 0001567619-21-000813 · doc1.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,577,420 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:08 UTC |
Medpace Investors, LLC10% owner
|
SaleCommon Stock | 10,127 | $140.01 | $1,417,881.27 |
DisclosureSEC source: 0001567619-21-000498 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,483,740 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $140.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:06 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 10,127 | $140.01 | $1,417,881.27 |
DisclosureSEC source: 0001567619-21-000496 · doc1.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,483,740 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $140.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 30, 2020 Filed Dec 31, 2020 19:34 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 19,930 | $140.01 | $2,790,399.30 |
DisclosureSEC source: 0001567619-20-021751 · doc1.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,493,867 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $140.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 30, 2020 Filed Dec 31, 2020 19:33 UTC |
Medpace Investors, LLC10% owner
|
SaleCommon Stock | 19,930 | $140.01 | $2,790,399.30 |
DisclosureSEC source: 0001567619-20-021750 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,493,867 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $140.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 21:07 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 1,374 | $140.00 | $192,360.00 |
DisclosureSEC source: 0001567619-20-021630 · doc1.xml · nonDerivative · entry 3 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,513,797 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 21:06 UTC |
Medpace Investors, LLC10% owner
|
SaleCommon Stock | 1,374 | $140.00 | $192,360.00 |
DisclosureSEC source: 0001567619-20-021629 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,513,797 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. Read SEC document |
| December 24, 2020 Filed Dec 29, 2020 21:07 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 3,829 | $140.00 | $536,060.00 |
DisclosureSEC source: 0001567619-20-021630 · doc1.xml · nonDerivative · entry 2 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,515,171 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 24, 2020 Filed Dec 29, 2020 21:06 UTC |
Medpace Investors, LLC10% owner
|
SaleCommon Stock | 3,829 | $140.00 | $536,060.00 |
DisclosureSEC source: 0001567619-20-021629 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,515,171 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. Read SEC document |
| December 23, 2020 Filed Dec 29, 2020 21:07 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $54.74 | $0.00 |
DisclosureSEC source: 0001567619-20-021630 · doc1.xml · derivative · entry 5 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,417 Underlying: Common Stock · 40,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested immediately upon issuance. Read SEC document |
| December 23, 2020 Filed Dec 29, 2020 21:07 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
Exercise / conversionCommon Stock | 40,000 | $54.74 | $2,189,600.00 |
DisclosureSEC source: 0001567619-20-021630 · doc1.xml · nonDerivative · entry 4 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2020 Filed Dec 29, 2020 21:07 UTC |
Troendle August J.Director · President & CEO · 10% owner
|
SaleCommon Stock | 3,547 | $140.11 | $496,970.17 |
DisclosureSEC source: 0001567619-20-021630 · doc1.xml · nonDerivative · entry 1 Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Medpace Investors, LLC Disclosed balance after: 6,519,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.